Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
Esperion's updated data from its recent cardiovascular trial is expected to influence investor perception and may impact the company’s market valuatio...
Read Full Article →